221 related articles for article (PubMed ID: 23913150)
1. Formulation development of antibody-drug conjugates.
Galush WJ; Wakankar AA
Methods Mol Biol; 2013; 1045():217-33. PubMed ID: 23913150
[TBL] [Abstract][Full Text] [Related]
2. Biotransformation and stability of antibody-drug conjugates: payload metabolism and linker cleavage delineation.
Rangan VS; Myler H; Kozhich A; Wang J; Randazzo R; Deshpande S
Bioanalysis; 2015; 7(11):1319-23. PubMed ID: 26110704
[No Abstract] [Full Text] [Related]
3. Analytical and bioanalytical technologies for characterizing antibody-drug conjugates.
Alley SC; Anderson KE
Curr Opin Chem Biol; 2013 Jun; 17(3):406-11. PubMed ID: 23570980
[TBL] [Abstract][Full Text] [Related]
4. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
Singh SK; Luisi DL; Pak RH
Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
[TBL] [Abstract][Full Text] [Related]
5. Chemical de-conjugation for investigating the stability of small molecule drugs in antibody-drug conjugates.
Chen T; Su D; Gruenhagen J; Gu C; Li Y; Yehl P; Chetwyn NP; Medley CD
J Pharm Biomed Anal; 2016 Jan; 117():304-10. PubMed ID: 26406314
[TBL] [Abstract][Full Text] [Related]
6. Antibody-drug conjugates- stability and formulation.
Duerr C; Friess W
Eur J Pharm Biopharm; 2019 Jun; 139():168-176. PubMed ID: 30940541
[TBL] [Abstract][Full Text] [Related]
7. Analytical methods for physicochemical characterization of antibody drug conjugates.
Wakankar A; Chen Y; Gokarn Y; Jacobson FS
MAbs; 2011; 3(2):161-72. PubMed ID: 21441786
[TBL] [Abstract][Full Text] [Related]
8. Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index.
Lyon RP; Bovee TD; Doronina SO; Burke PJ; Hunter JH; Neff-LaFord HD; Jonas M; Anderson ME; Setter JR; Senter PD
Nat Biotechnol; 2015 Jul; 33(7):733-5. PubMed ID: 26076429
[TBL] [Abstract][Full Text] [Related]
9. Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.
McCombs JR; Owen SC
AAPS J; 2015 Mar; 17(2):339-51. PubMed ID: 25604608
[TBL] [Abstract][Full Text] [Related]
10. Characterization of antibody-drug conjugates by mass spectrometry: advances and future trends.
Huang RY; Chen G
Drug Discov Today; 2016 May; 21(5):850-5. PubMed ID: 27080148
[TBL] [Abstract][Full Text] [Related]
11. Linker technologies for antibody-drug conjugates.
Nolting B
Methods Mol Biol; 2013; 1045():71-100. PubMed ID: 23913142
[TBL] [Abstract][Full Text] [Related]
12. An emerging playbook for antibody-drug conjugates: lessons from the laboratory and clinic suggest a strategy for improving efficacy and safety.
Drake PM; Rabuka D
Curr Opin Chem Biol; 2015 Oct; 28():174-80. PubMed ID: 26342601
[TBL] [Abstract][Full Text] [Related]
13. Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates?
D'Atri V; Pell R; Clarke A; Guillarme D; Fekete S
J Chromatogr A; 2019 Feb; 1586():149-153. PubMed ID: 30554777
[TBL] [Abstract][Full Text] [Related]
14. Current ADC Linker Chemistry.
Jain N; Smith SW; Ghone S; Tomczuk B
Pharm Res; 2015 Nov; 32(11):3526-40. PubMed ID: 25759187
[TBL] [Abstract][Full Text] [Related]
15. Physical and Chemical Stability of Antibody Drug Conjugates: Current Status.
Ross PL; Wolfe JL
J Pharm Sci; 2016 Feb; 105(2):391-397. PubMed ID: 26869406
[TBL] [Abstract][Full Text] [Related]
16. Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification.
Su D; Kozak KR; Sadowsky J; Yu SF; Fourie-O'Donohue A; Nelson C; Vandlen R; Ohri R; Liu L; Ng C; He J; Davis H; Lau J; Del Rosario G; Cosino E; Cruz-Chuh JD; Ma Y; Zhang D; Darwish M; Cai W; Chen C; Zhou H; Lu J; Liu Y; Kaur S; Xu K; Pillow TH
Bioconjug Chem; 2018 Apr; 29(4):1155-1167. PubMed ID: 29481745
[TBL] [Abstract][Full Text] [Related]
17. Selecting an optimal antibody for antibody-drug conjugate therapy: internalization and intracellular localization.
Harper J; Mao S; Strout P; Kamal A
Methods Mol Biol; 2013; 1045():41-9. PubMed ID: 23913140
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
[TBL] [Abstract][Full Text] [Related]
19. Current approaches for the purification of antibody-drug conjugates.
Matsuda Y
J Sep Sci; 2022 Jan; 45(1):27-37. PubMed ID: 34473399
[TBL] [Abstract][Full Text] [Related]
20. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
Chadha R; Bhandari S
J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
